Clinical Trial

Right Ventricular Dysfunction in Chronic Heart Failure

Study acronym: RIVED-CHF
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 21, 2023 (before its estimated March 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
The goal of this multi center observational prospective study is to analyze the concordance between the signs and symptoms of RHF and echocardiographic features of RVD in patient with heart failure. The main questions it aims to answer are: 1. to assess the incidence of RVH and RVD in each HF subtypes. 2. to evaluate prognostic impact ( in terms of cardiovascular mortality and HF hospitalization) of different RVD patterns during a mean followup period of 3 years 3. To investigate the incidence of different RV maladaptation ( isolated RV dilatation, isolated Pulmonary hypertension, combined pattern) in each HF groups and the related outcome. Participants will follow by direct check up visit and/or virtual visits every 6 months for a mean follow-up period of 3 years.
Trial Details
NCT Number NCT06002321
Lead Sponsor University of Siena
Collaborators: Italian Society of Cardiology
Conditions Chronic Heart Failure, Right Ventricular Dysfunction, Right Heart Failure
Enrollment 1,000 participants
Start Date 2023-09-01
Primary Completion 2024-03-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2023-08-21